A federal decide allowed lawsuits to maneuver forward alleging that taking Tylenol whereas pregnant will increase the dangers of a kid being identified with autism or ADHD.
On Thursday, U.S. District Decide Denise Cote, within the Southern District of New York, denied Johnson & Johnson’s movement, which insisted that U.S. Meals and Drug Administration laws preempted claims that it did not warn of Tylenol’s prenatal dangers. Cote discovered Johnson & Johnson may add to Tylenol’s warning label, which advises ladies who’re pregnant or breastfeeding to “ask a well being skilled earlier than use.”
